Open AccessThe REACH Trial: A Randomized Controlled Trial Assessing the Safety and Effectiveness of the Spiration® Valve System in the Treatment of Severe Emphysema
Author(s) -
Shiyue Li,
Guangfa Wang,
Changhui Wang,
Xiaowen Gao,
Fang Jin,
Huanming Yang,
Baohui Han,
Rui Zhou,
Chengshui Chen,
Liang-An Chen,
Chunxue Bai,
Huahao Shen,
Felix J.F. Herth,
Nanshan Zhong
Publication year - 2018
Publication title -
respiration
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.264
H-Index - 81
eISSN - 1423-0356
pISSN - 0025-7931
DOI - 10.1159/000494327
Subject(s) - medicine , randomized controlled trial , physical therapy , intensive care medicine , surgery
Chronic obstructive pulmonary disease (COPD) has become a leading cause of morbidity and mortality in China, with tobacco smoke, air pollution, and occupational biohazards being the major risk factors.